Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03827473
Title Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (ACADEMIC)
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Docetaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.